Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.
C-peptide and proinsulin and related variables
Insulin secretion
Multiple daily insulin injections
Type 2 diabetes mellitus
Journal
Primary care diabetes
ISSN: 1878-0210
Titre abrégé: Prim Care Diabetes
Pays: England
ID NLM: 101463825
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
15
01
2020
revised:
31
08
2020
accepted:
11
11
2020
pubmed:
12
12
2020
medline:
16
10
2021
entrez:
11
12
2020
Statut:
ppublish
Résumé
From the MDI-liraglutide study, we evaluated variables associated with endogenous insulin production in persons with multiple daily insulin injections-treated type 2 diabetes by relating C-peptide, proinsulin and proinsulin/C-peptide ratio at baseline to baseline variables. Lower insulin production was related to longer diabetes duration, shorter abdominal sagittal diameter and more glycaemic variability.
Identifiants
pubmed: 33303380
pii: S1751-9918(20)30321-1
doi: 10.1016/j.pcd.2020.11.005
pii:
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Insulin
0
Liraglutide
839I73S42A
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
607-613Informations de copyright
Copyright © 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.